Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies ...
eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...
On February 3, 2026, President Trump signed H.R.7148, the Consolidated Appropriations Act, 2026, into law. Section 6703 of the Act, ...
Transforming the chemicals industry, AI application models enhance formulation development, enabling rapid, accurate responses to evolving market demands.
CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
Pediatric populations represent the most diverse patient groups in all of medicine. Factors such as individual preferences, physiology, and dosage considerations all serve to complicate drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results